{"recordId":"st_5xzzap9vv8kvdwde","canonicalUrl":"https://sotwire.com/stories/slate-medicines-adds-brannan-young-board-raleigh","jsonUrl":"https://sotwire.com/stories/slate-medicines-adds-brannan-young-board-raleigh/record","slug":"slate-medicines-adds-brannan-young-board-raleigh","headline":"Slate Medicines adds two drug industry veterans to its board","dek":"The Raleigh migraine drug developer named former Karuna Therapeutics CMO Stephen Brannan and former Pfizer executive John Young.","articleBody":"Slate Medicines, a Raleigh clinical-stage biotechnology company developing treatments for migraine and other headache disorders, announced on Oct. 20, 2026, that Stephen K. Brannan, MD, and John D. Young have joined its board of directors.\n\nBrannan was chief medical officer of Karuna Therapeutics from 2017 until 2024, overseeing development of KarXT through Phase 3 trials in schizophrenia, the program that led to the approval of Cobenfy. He earlier held clinical and medical leadership roles at Forum Pharmaceuticals, Takeda, Novartis, Cyberonics and Eli Lilly, according to the release.\n\nYoung retired from Pfizer in 2022 after a 35-year career, most recently as group president and chief business officer and a member of the company's executive leadership team. He serves on the boards of Novartis AG and Johnson Controls International.\n\nSlate's lead candidate is SLTE-1009, a clinical-stage anti-PACAP/VIP monoclonal antibody designed for infrequent subcutaneous dosing. \"Their guidance will be invaluable as we advance SLTE-1009 as well as our portfolio and work to bring much-needed new treatment options to migraine patients who remain underserved by current therapies,\" CEO Gregory Oakes said in the release.","category":"hire","categoryLabel":"Hires","location":"Raleigh, NC","company":{"name":"Slate Medicines","domain":"slatemedicines.com"},"sample":false,"sampleDisclaimer":null,"publishedAt":"2026-10-26T13:56:16.903Z","updatedAt":"2026-10-26T13:56:16.903Z","badge":"Desk reported","trust":{"level":"desk_reported","doctrine":"Sotwire verifies who at the company stood behind the submission. It does not independently certify every underlying company claim as true.","verifies":"which named Sotwire editor wrote this from the cited sources","doesNotCertify":"independent truth of every claim","badge":"Desk reported","verificationMethod":"Named Sotwire editor, from the cited sources. Not a company attestation, and not an independent fact-check of every sentence.","domainChecked":false},"attestation":{"attested":false},"confirmation":null,"facts":[{"label":"New directors","value":"Stephen K. Brannan, MD; John D. Young"},{"label":"Announced","value":"Oct. 20, 2026"},{"label":"Brannan","value":"Chief medical officer, Karuna Therapeutics, 2017 to 2024"},{"label":"Young","value":"Retired from Pfizer in 2022 as group president and chief business officer"},{"label":"Lead program","value":"SLTE-1009, anti-PACAP/VIP monoclonal antibody"},{"label":"CEO","value":"Gregory Oakes"}],"keyEvents":[{"date":"2026-10-20","label":"Slate Medicines announced the board appointments"}],"sources":[{"url":"https://www.globenewswire.com/news-release/2026/10/20/3384223/0/en/slate-medicines-strengthens-board-of-directors-with-appointment-of-stephen-k-brannan-md-and-john-d-young.html","title":"Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young","publisher":"Slate Medicines via GlobeNewswire"},{"url":"https://slatemedicines.com/news/slate-medicines-strengthens-board-of-directors-with-appointment-of-stephen-k-brannan-md-and-john-d-young/","title":"Slate Medicines Strengthens Board of Directors with Appointment of Stephen K. Brannan, MD, and John D. Young","publisher":"Slate Medicines"},{"url":"https://www.biobuzz.io/news/north-carolina-life-sciences-news-fortreas-45-million-acquisition-united-therapeutics-fda-approval-more/","title":"North Carolina Life Sciences News: Fortrea's $45 Million Acquisition, United Therapeutics FDA Approval & More","publisher":"BioBuzz"}],"source":{"url":"https://www.globenewswire.com/news-release/2026/10/20/3384223/0/en/slate-medicines-strengthens-board-of-directors-with-appointment-of-stephen-k-brannan-md-and-john-d-young.html","publisher":"Slate Medicines","publishedAt":"2026-10-20T11:00:00.000Z"},"cover":{"url":"https://sotwire.com/covers/slate-medicines-adds-brannan-young-board-raleigh.webp","alt":"Slate Medicines adds two drug industry veterans to its board","provenance":"unknown","provenanceLabel":"Unknown origin","credit":null},"images":[],"provenanceMethod":"EXIF, XMP, and filename heuristic. Not C2PA cryptographic proof, and not a judgment that the depicted event is true.","provenanceDisclaimer":"v1 labels are heuristic (EXIF, XMP, filename), not cryptographic C2PA proof. Treat them as disclosure of observed metadata, not a guarantee that the image is genuine or that the depicted event is true.","citation":"Sotwire Desk, Slate Medicines. \"Slate Medicines adds two drug industry veterans to its board.\" Sotwire, October 26, 2026, https://sotwire.com/stories/slate-medicines-adds-brannan-young-board-raleigh. Record ID: st_5xzzap9vv8kvdwde. Desk reported.","sampleLabel":null,"correctionStatus":"No public corrections recorded","integrity":{"algorithm":"sha-256","hex":"8b5fd62fe8e380787e36b9257c5a91f2a6723e151f258c97ab086301b766357a","contentDigest":"sha-256=:i1/WL+jjgHh+NrklfFqR8qZyPhUfJYyXqwhjAbdmNXo=:","scope":"Canonical JSON record excluding the integrity object"}}